Made in Emerging Europe

Made in emerging Europe: Resysten

emerging europe coronavirus infection resysten

Emerging Europe’s start-up scene is thriving: new money and new ideas are coming onto the market all the time. To keep you up to date with the latest investments, innovations, events and accelerators, every week Emerging Europe brings you a round-up of the region’s start-up news.

Hungary’s Resysten secures 1.84 million euros funding to continue global expansion

CleanTech start-up Resysten is set to embark on further global expansion after agreeing a 750 million forint (1.84 million euros) capital injection from Columbus Private Equity Fund, which will be used to develop its laboratory and research base in addition to its overseas presence.

The family-owned company’s proprietary hygiene coating prevents pathogens from adhering to any surface for up to a full year. The coating is invisible, colourless, odourless and uses the properties of photo-oxidation to neutralise harmful substances; by the energy of light (whether natural or artificial) to protect surfaces from viruses, bacteria and other microbes.

Resysten reduces the presence of pathogens  on any surface by up to 99 per cent for up to a year, effectively supporting cleaning and disinfection protocols and helping businesses and institutions to operate in a more sustainable way.

Resysten is currently used on Hungarian public transport, including the Budapest metro network and Volánbus coaches as well as in Hungarian hospitals and shopping centres, sports facilities, manufacturing facilities and public spaces.

The firm’s services are also available in Great Britain, the US, Ireland, Spain, Italy, Czechia, Romania, Taiwan and Macau, and has grown steadily to become a medium-sized business with a turnover of over 500 billion forints (1.22 million euros) last year following a considerable expansion after the Covid pandemic.

“In today’s globalised world, the spread of viruses and bacteria has accelerated dramatically which, together with the increasing diversification of pathogens, has created a new challenge for companies and institutions. We believe that the integration of new technologies into our daily lives is essential for effective protection,” says Péter Lehoczky, one of the company’s founding owners and managing director.

“Our aim is not only to continue to expand in Hungary, but to expand globally. In order to achieve this goal, we knew we needed an investment partner who would provide us not only with the necessary capital, but also the expertise and contacts to secure our expansion.”

Unlike many news and information platforms, Emerging Europe is free to read, and always will be. There is no paywall here. We are independent, not affiliated with nor representing any political party or business organisation. We want the very best for emerging Europe, nothing more, nothing less. Your support will help us continue to spread the word about this amazing region.

You can contribute here. Thank you.

emerging europe support independent journalism